ReviewPharmaceuticals (Basel, Switzerland)2023

Reviving a Classic Antigen with a Cutting-Edge Approach: Nanobodies for HER2+ Breast Cancer.

Chiara Castrignano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.